Only Covance combines one of the world’slargest sources of de-identified lab resultsandpatient intelligence datawithinvestigator datafrom the majority ofglobal clinical trialsthat provide insights to increase efficiencies and effectiveness in clinical drug development.
Find patients that Meet Your Inclusion/Exclusion Criteria
Using LabCorp’s real world, de-identified clinical laboratory data on over 150 million patients, we can assess populations who meet your protocol’s eligibility criteria, accurately model the impact that the protocol inclusion/exclusion criteria will have on the patient pool size and geo-locate
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
*Savings based on an analysis of trials processed through Covance Central Labs with Protocol Finalization date after 1/1/2009 for the specific clinical indications. Past performance is not a guarantee of future results, and a variety of factors other than CRO performance can impact timing of clinical studies.